Sustainable Practices and Their Impacts in the Pharmaceutical Supply Chain: Insights from Top Five Companies
Keywords:
Pharmaceutical industry, sustainability, supply chain management, environmental performance, operational efficiency, corporate social responsibility, waste management, renewable energy, procurement practices, logistics optimizationAbstract
Sustainability has become a critical focus in the pharmaceutical industry, driven by regulatory requirements, market demands and corporate social responsibility. This paper investigates sustainable practices adopted by five leading pharmaceutical companies: Pfizer, Johnson & Johnson, AbbVie, Merck & Co., and Roche. The study explores their impacts on operational efficiency, environmental performance and competitive advantage through a detailed analysis of procurement, logistics, waste management and manufacturing processes. By examining these industry leaders, we identify key drivers, barriers and future trends in pharmaceutical supply chain sustainability. The research reveals significant progress in areas such as supplier engagement, transportation optimization, waste reduction and renewable energy adoption. A conceptual framework is proposed to illustrate the integration of sustainable practices, their impacts and feedback mechanisms in the pharmaceutical supply chain. This study offers valuable insights for advancing sustainability in global supply chains and provides a roadmap for pharmaceutical companies seeking to enhance their environmental performance while maintaining operational efficiency and competitive advantage.
Published
Issue
Section
Copyright (c) 2025 International Journal of Pharmaceuticals and Health Care Research

This work is licensed under a Creative Commons Attribution 4.0 International License.